Insider Transactions in Q2 2022 at Gain Therapeutics, Inc. (GANX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2022
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
2,482
+1.13%
|
$4,964
$2.58 P/Share
|
|
May 20
2022
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
9,256
+4.12%
|
$18,512
$2.83 P/Share
|
|
May 19
2022
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
4,000
+1.9%
|
$8,000
$2.71 P/Share
|
|
May 19
2022
|
Salvatore Calabrese Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+27.03%
|
$24,300,000
$8100.0 P/Share
|